Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.4.417

Transplantation of Brain-Derived Neurotrophic Factor-Expressing Mesenchymal Stem Cells Improves Lower Urinary Tract Symptoms in a Rat Model  

Jeon, Seung Hwan (Department of Urology, College of Medicine, The Catholic University of Korea)
Park, Mi-Young (Department of Clinical Laboratory Science, Suwon Science College)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.4, 2020 , pp. 417-424 More about this Journal
Abstract
This study aimed to explore the effects of brain-derived neurotrophic factor (BDNF), produced by engineered immortalized mesenchymal stem cells (imMSC), on lower urinary tract symptoms (LUTS) in a rat model with neurogenic bladder (NB). Forty-eight Sprague-Dawley (SD) rats were randomly divided into the following groups: Sham control, LUTS, LUTS+imMSC (treated with immortalized MSC), and LUTS+BDNF-eMSC (treated with BDNF-expressing MSC) groups. LUTS was induced by a crush injury to the major pelvic ganglion (MPG). Bladder function was tested under anesthesia, and bladder tissue strips were collected thereafter for contractility test and western blot analysis. Western blot results showed that the expression of both Angiopoietin 1 (Ang 1) and platelet-derived growth factor (PDGF) increased with MSC injection. The effect of treatment with BDNF-eMSC on LUTS was also evaluated, and the results were found to be better than those with imMSC (P<0.05). BDNF-eMSC prevented fibrosis in the bladder tissue and significantly reduced caspase-3 levels. In conclusion, high expression of BDNF in vivo resulted in recovery of bladder function and contractility, along with the inhibition of apoptosis in a rat model.
Keywords
Bladder function; Brain-derived neurotrophic factor; Lower urinary tract symptoms;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Eveno C, Lamblin A, Mariette C, Pocard M. Sexual and urinary dysfunction after proctectomy for rectal cancer. J Visc Surg. 2010;147:e21-30. https://doi.org/10.1016/j.jviscsurg.2010.02.001   DOI
2 Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh SJ, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018;36:1517-1527. https://doi.org/10.1007/s00345-018-2301-z   DOI
3 Atala A. Reconstitution of experimental neurogenic bladder dysfunction using skeletal muscle-derived multipotent stem cells. J Urol. 2011;185:353. https://doi.org/10.1016/S0022-5347(11)60069-4   DOI
4 Fandel TM, Albersen M, Lin G, Qiu X, Ning H, Banie L, et al. Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol. 2012;61:201-210. https://doi.org/10.1016/j.eururo.2011.07.061   DOI
5 Gong M, Bi Y, Jiang W, Zhang Y, Chen L, Hou N, et al. Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies. J Biomed Sci. 2011;18:87. https://doi.org/10.1186/1423-0127-18-87   DOI
6 Kutlu O, Yalcinkaya M, Kutlu S, Elpek GO, Koksal IT, Kukul E. Effect of doxazosin on expression of eNOS in rat kidney in the presence of partial bladder outlet obstruction. J Nephrol. 2012; 25:750-754. https://doi.org/10.5301/jn.5000055   DOI
7 Kim SO, Song SH, Hwang EC, Park KS, Kwon DD, Ahn KY, et al. The expression of AQP1 and eNOS in menopausal rat urinary bladder. Int Neurourol J. 2010;14:78-85. https://doi.org/10.5213/inj.2010.14.2.78   DOI
8 Jeon SH, Zhu GQ, Bae WJ, Choi SW, Jeong HC, Cho HJ, et al. Engineered mesenchymal stem cells expressing stromal cell-derived factor-1 improve erectile dysfunction in streptozotocin-induced diabetic rats. Int J Mol Sci. 2018;19. https://doi.org/10.3390/ijms19123730   DOI
9 Leiria LO, Sollon C, Bau FR, Monica FZ, D'Ancona CL, De Nucci G, et al. Insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response-dependent insulin resistance as a cause of obesity-associated overactive bladder. J Physiol. 2013;591:2259-2273. https://doi.org/10.1113/jphysiol.2013.251843   DOI
10 Jeon SH, Shrestha KR, Kim RY, Jung AR, Park YH, Kwon O, et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology. 2016;88:226.e1-9. https://doi.org/10.1016/j.urology.2015.10.021   DOI
11 Matthes SM, Reimers K, Janssen I, Liebsch C, Kocsis JD, Vogt PM, et al. Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration. Biomed Res Int. 2013; 2013:573169. https://doi.org/10.1155/2013/573169   DOI
12 Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712. https://doi.org/10.1038/nm0603-702   DOI
13 Zhu GQ, Jeon SH, Lee KW, Cho HJ, Ha US, Hong SH, et al. Engineered stem cells improve neurogenic bladder by over-expressing SDF-1 in a pelvic nerve injury rat model. Cell Transplant. 2020;29:963689720902466. https://doi.org/10.1177/0963689720902466   DOI
14 Liu TM, Ng WM, Tan HS, Vinitha D, Yang Z, Fan JB, et al. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev. 2013;22: 268-278. https://doi.org/10.1089/scd.2012.0222   DOI
15 Hoen L, Ecclestone H, Blok BFM, Karsenty G, Phe V, Bossier R, et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review. Neurourol Urodyn. 2017;36:1685-1702. https://doi.org/10.1002/nau.23205   DOI
16 Kim DH, Zhao X. BDNF protects neurons following injury by modulation of caspase activity. Neurocrit Care. 2005;3:71-76. https://doi.org/10.1385/NCC:3:1:071   DOI
17 Nelson KR, Stevens SM, McLoon LK. Prolongation of relaxation time in extraocular muscles with brain derived neurotrophic factor in adult rabbit. Invest Ophthalmol Vis Sci. 2016;57:5834-5842. https://doi.org/10.1167/iovs.16-19679   DOI
18 Willoughby CL, Fleuriet J, Walton MM, Mustari MJ, McLoon LK. Adaptation of slow myofibers: the effect of sustained BDNF treatment of extraocular muscles in infant nonhuman primates. Invest Ophthalmol Vis Sci. 2015;56:3467-3483. https://doi.org/10.1167/iovs.15-16852   DOI
19 Pelegri NG, Gorrie CA, Santos J. Rat hippocampal neural stem cell modulation using PDGF, VEGF, PDGF/VEGF, and BDNF. Stem Cells Int. 2019;2019:4978917. https://doi.org/10.1155/2019/4978917   DOI
20 Yiou R, Hamidou L, Birebent B, Bitari D, Lecorvoisier P, Contremoulins I, et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: An open dose-escalation pilot study. Eur Urol. 2016;69:988-991. https://doi.org/10.1016/j.eururo.2015.09.026   DOI
21 Wein AJ. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review. J Urol. 2019;201:38-39. https://doi.org/10.1097/01.ju.0000550215.07396.8e   DOI
22 Rabie MA, Abd El Fattah MA, Nassar NN, El-Abhar HS, Abdallah DM. Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-kappaB axis. Biochem Pharmacol. 2018;151:126-134. https://doi.org/10.1016/j.bcp.2018.01.047   DOI